Back to Search
Start Over
Pharmacokinetics, Efficacy, and Safety of a SARS-CoV-2 Antibody Treatment in Pediatric Participants: An Open-Label Addendum of a Placebo-Controlled, Randomized Phase 2/3 Trial
- Source :
- Infectious Diseases and Therapy, Vol 12, Iss 7, Pp 1861-1873 (2023)
- Publication Year :
- 2023
- Publisher :
- Adis, Springer Healthcare, 2023.
-
Abstract
- Abstract Introduction Bamlanivimab and etesevimab (BAM + ETE) are monoclonal antibodies (mAbs) effective in reducing COVID-19-related hospitalizations and all-cause mortality in adult participants at increased risk for severe disease. We present pharmacokinetic (PK), efficacy, and safety results from pediatric participants ( 12 to
Details
- Language :
- English
- ISSN :
- 21938229 and 21936382
- Volume :
- 12
- Issue :
- 7
- Database :
- Directory of Open Access Journals
- Journal :
- Infectious Diseases and Therapy
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.4a8e4f959324473bb550800f3098224f
- Document Type :
- article
- Full Text :
- https://doi.org/10.1007/s40121-023-00832-y